BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 6334353)

  • 1. [Theoretical objective evaluation of the value of a diagnostic criterion. Application to antinuclear antibodies for the diagnosis of systemic lupus erythematosus].
    Vinceneux P; Yeni P; Boboc B; Carbon C
    Rev Rhum Mal Osteoartic; 1984 Oct; 51(9):493-6. PubMed ID: 6334353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-telomere antibodies in systemic lupus erythematosus (SLE): a comparison with five antinuclear antibody assays in 430 patients with SLE and other rheumatic diseases.
    Salonen EM; Miettinen A; Walle TK; Koskenmies S; Kere J; Julkunen H
    Ann Rheum Dis; 2004 Oct; 63(10):1250-4. PubMed ID: 15361381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnostic approaches in systemic lupus erythematosus (author's transl)].
    Häcki MA; Grob PJ
    Dtsch Med Wochenschr; 1976 Jan; 101(1):13-6. PubMed ID: 1106979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
    Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K
    Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early undifferentiated connective tissue disease. II. The frequency of circulating antinuclear antibodies in patients with early rheumatic diseases.
    Clegg DO; Williams HJ; Singer JZ; Steen VD; Schlegel S; Ziminski C; Alarcón GS; Luggen ME; Polisson RP; Willkens RF
    J Rheumatol; 1991 Sep; 18(9):1340-3. PubMed ID: 1757935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic and prognostic significance of different antinuclear antibodies in more than 1000 consecutive Albanian patients with rheumatic diseases.
    Sulcebe G; Morcka K
    Clin Exp Rheumatol; 1992; 10(3):255-61. PubMed ID: 1582070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of dsDNA binding to SmD-derived peptides on clinical accuracy in the diagnosis of systemic lupus erythematosus.
    Mahler M; Waka A; Hiepe F; Fritzler MJ
    Arthritis Res Ther; 2007; 9(4):R68. PubMed ID: 17640359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Information on diagnosis and management of systemic lupus erythematosus derived from the routine measurement of 8 nuclear autoantibodies.
    Ignat GP; Rat AC; Sychra JJ; Vo J; Varga J; Teodorescu M
    J Rheumatol; 2003 Aug; 30(8):1761-9. PubMed ID: 12913932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The autoantibody profile and disease activity in patients with systemic lupus erythematosus].
    Horák P; Hermanová Z; Faltýnek L; Pospísil Z; Scudla V
    Vnitr Lek; 1997 Oct; 43(10):639-44. PubMed ID: 9601876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of antinuclear antibodies: comparative evaluation of enzyme immunoassay and indirect immunofluorescence methods.
    Homburger HA; Cahen YD; Griffiths J; Jacob GL
    Arch Pathol Lab Med; 1998 Nov; 122(11):993-9. PubMed ID: 9822128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antibodies against native deoxyribonucleic acid (anti-nDNA) without antinuclear antibodies: clinical significance (author's transl)].
    Abegg A; Enzler P; Grob PJ
    Dtsch Med Wochenschr; 1980 Sep; 105(37):1273-9. PubMed ID: 6998692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnostic significance of antinuclear antibodies].
    Swaak AJ
    Ned Tijdschr Geneeskd; 2000 Mar; 144(13):585-9. PubMed ID: 10761543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The clinical immunology laboratory in diagnosis and monitoring of systemic lupus erythematosus and connective tissue diseases].
    Sinico RA; Radice A
    G Ital Nefrol; 2005; 22 Suppl 33():S21-6. PubMed ID: 16419001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VH4-34 encoded antibodies in systemic lupus erythematosus: a specific diagnostic marker that correlates with clinical disease characteristics.
    van Vollenhoven RF; Bieber MM; Powell MJ; Gupta PK; Bhat NM; Richards KL; Albano SA; Teng NN
    J Rheumatol; 1999 Aug; 26(8):1727-33. PubMed ID: 10451069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Disseminated lupus erythematosus without antinuclear antibodies or other autoantibodies].
    Duc J; Perroulaz G; Golaz J; Campiche M; Pécoud A
    Schweiz Med Wochenschr; 1987 Feb; 117(6):205-8. PubMed ID: 3494306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Serum anti-dsDNA antibodies in lupus nephritis].
    Fiorentini GP; Cagnoli L
    Boll Soc Ital Biol Sper; 1981 Sep; 57(18):1890-5. PubMed ID: 7032540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Systemic lupus erythematosus in children with renal and hematologic manifestations. Relation to anti-nDNA antibodies].
    Martínez-Cordero E; Riebeling-Navarro CG; López-Zepeda J; Martínez-Miranda E; Negrete-García MC
    Bol Med Hosp Infant Mex; 1989 Jan; 46(1):11-21. PubMed ID: 2785391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of severity and native anti-DNA antibody levels in systemic lupus erythematosus. Serodiscordant lupus].
    Manent-Ducreuzet C; Margulis J; Kahn MF
    Rev Rhum Mal Osteoartic; 1981 Nov; 48(11):705-12. PubMed ID: 6975965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of laboratory tests in diagnosis and monitoring of systemic lupus erythematosus.
    Sinico RA; Bollini B; Sabadini E; Di Toma L; Radice A
    J Nephrol; 2002; 15 Suppl 6():S20-7. PubMed ID: 12515370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seronegative systemic lupus erythematosus.
    Bohan A
    J Rheumatol; 1979; 6(5):534-40. PubMed ID: 93147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.